HoffmanBFRosenMR. Cellular mechanisms for cardiac arrhythmias. Circ Res1981; 49: 1–15.
2.
WellensHJJ. Electrical stimulation of the heart in the study and treatment of tachycardias. Baltimore: University Park Press, 1977.
3.
FerrierGRSaundersJHMendezC.A cellular mechanism for the generation of ventricular arrhythmias by acetylotrophanthiden. Circ Res1973; 32: 600–9.
4.
WitALCranefieldPF. Triggered activity in cardiac muscle fibers of the simian mitral valve. Circ Res1976; 38: 85–98.
5.
LownBGraboysTB. Management of patients with malignant ventricular arrhythmias. Am J Cardiol1977; 39: 910–8.
6.
WinkleRAAldermanELFitzgeraldJW, Treatment of recurrent symptomatic ventricular tachycardia. Ann Intern Med1976; 85: 1–7.
7.
MorganrothJMichelsonELHorowitzLN, Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation1978; 58: 408–14.
8.
WinkleRA. Antiarrhythmic drug effect mimicked by spontaneous morbidity of ventricular ectopy. Circulation1978; 57: 1116–21.
9.
HerlingIMHorowitzLNJosephsonME. Ventricular ectopic activity following medical and surgical treatment for recurrent sustained ventricular tachycardia. Am J Cardiol1980; 45: 633–9.
10.
WinkleRAGradmanAHFitzgeraldJWBellPA. Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: Comparison of propranolol, procainamide and quinidine. Am J Cardiol1978; 42: 473–80.
11.
ShepsDSErnstJCBrieseFR, Decreased frequency of exercise-induced ventricular ectopic activity in the second of two consecutive treadmill tests. Circulation1977; 55: 892–5.
12.
VandePolCJFarshidiASpielmanSRGreenspanAMHorowitzLNJosephsonME. The incidence and clinical significance of induced ventricular tachycardia. Am J Cardiol1980; 45: 725–31.
13.
HorowitzLNJosephsonMEFarshidiASpielmanSRMichelsonELGreenspanAM. Recurrent sustained ventricular tachycardia: 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation1978; 58: 986–97.
14.
HorowitzLNJosephsonMEKastorJA. Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia. Prog Cardiovasc Dis1980; 23: 81–98.
15.
WuDDenesPAmat-Y-LeonF, Clinical, electrocardiographic and electrophysiologic observations in patients with paroxysmal supraventricular tachycardia. Am J Cardiol1978; 41: 1045–51.
16.
BauerfeindRAWyndhamCRDhingraRC, Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia. Circulation1980; 62: 1341–99.
17.
BiggerJTGoldreyerBN. The mechanism of supraventricular tachycardia. Circulation1970; 42: 673–88.
18.
DenesPWuDDhingraRCChuguimiaRRosenKM. Demonstration of dual AV nodal pathways in patients with paroxysmal supraventricular tachycardia. Circulation1973; 48: 549–55.
19.
WellensHJJDurrerD.The role of an accessory atrioventricular pathway in reciprocal tachycardia. Observations in patients with and without the Wolff-Parkinson-White syndrome. Circulation1975; 52: 58–72.
20.
NeussHSchlepperMThormannJ.Analysis of reentry mechanisms in three patients with concealed Wolff-Parkinson-White syndrome. Circulation1975; 51: 75–81.
21.
WuDDenesPDhingraRKhanARosenKM. The effects of propranolol on induction of AV nodal reentrant paroxysmal tachycardia. Circulation1974; 50: 665–77.
22.
WuDWyndhamCRAmat-Y-LeonFDenesPDhingraRCRosenKM. The effects of ouabain on induction of atrioventricular nodal reentrant paroxysmal tachycardia. Circulation1975; 52: 201–7.
23.
WellensHJJTanSLBarFWHDurenDRLieKIDohmenHM. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal reentrant supraventricular tachycardia. Br Heart J1977; 39: 1058–66.
24.
WuDDenesPBauerfeindRKehoeRAmat-Y-LeonFRosenKM. Effects of procainamide on atrioventricular nodal reentrant paroxysmal tachycardia. Circulation1978; 57: 1171–9.
25.
WuDAmat-Y-LeonFSimpsonRJ, Electrophysiological studies with multiple drugs in patients with atrioventricular reentrant tachycardias utilizing an extranodal pathway. Circulation1977; 56: 727–36.
26.
FisherJDCohenHLMehraR, Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. Am Heart J1977; 93: 658–68.
27.
GrohWCKastorJAJosephsonMEHorowitzLN. Amiodarone: An effective drug for refractory ventricular tachycardia. Circulation1980; 62: 111–52.
28.
KaskiJCGirottiLAMessutiHRutitzkyBRosenbaumMB. Long-term management of sustained recurrent symptomatic ventricular tachycardia with amiodarone. Circulation1981; 64: 273–9.
29.
MasonJWWinkleRA. Electrode catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation1978; 58: 971–85.
30.
RuskinJNDiMarcoJPGaranH.Out-of-hospital cardiac arrest. Electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med1980; 303: 607–13.
31.
HorowitzLNSpielmanSRGreenspanAMJosephsonME. The role of programmed stimulation assessing vulnerability to ventricular arrhythmia in man. Am Heart J1982(Apr): In press.
32.
SpielmanSRFarshidiAHorowitzLNJosephsonME. Ventricular fibrillation during programmed ventricular stimulation: Incidence and clinical implications. Am J Cardiol1978; 42: 913–8.
